USANA Health Sciences, Inc.
USNA · NYSE
12/28/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $2 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -7.2% | -7.8% | -15.8% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 79.4% | 79.4% | 79.2% | 80.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 11.6% | 13.4% | 13% | 16.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 4.9% | 6.9% | 6.9% | 9.8% |
| EPS Diluted | 2.19 | 3.3 | 3.59 | 5.73 |
| % Growth | -33.6% | -8.1% | -37.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |